BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3341783)

  • 1. [Treatment of prostatic cancer].
    Shimazaki J; Fuse H; Akimoto S; Akakura K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):212-8. PubMed ID: 3341783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate cancer].
    Shimazaki J; Isaka S; Akakura K; Akimoto S; Morita S
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2092-7. PubMed ID: 9388518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis of the patients with prostate cancer clinically confined within the pelvis].
    Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T
    Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic carcinoma. I: Androgen dependency of prostatic carcinoma].
    Shimazaki J; Fuse H; Akimoto S; Sumiya H; Akakura K; Ichikawa T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):909-16. PubMed ID: 3389834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrine therapy of prostatic cancer].
    Shimazaki J; Fuse H; Zama S
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1195-201. PubMed ID: 4057576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation.
    Zagars GK; Pollack A; von Eschenbach AC
    Cancer; 1997 Aug; 80(4):764-75. PubMed ID: 9264361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
    Faul P
    Eur Urol; 1992; 22(2):89-98. PubMed ID: 1478236
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
    Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
    Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do radiotherapy and immediate orchiectomy yield comparable results as radical prostatectomy, adjuvant irradiation and orchiectomy in patients with stage D1 of prostatic carcinoma?].
    Wiegel T
    Strahlenther Onkol; 1995 Aug; 171(8):480-1. PubMed ID: 7652675
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of prostate cancer with regional lymph node (N1) metastasis.
    Pollack A; Horwitz EM; Movsas B
    Semin Radiat Oncol; 2003 Apr; 13(2):121-9. PubMed ID: 12728441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Response to chemotherapy in endocrine therapy-relapsed and -resistant prostate cancer].
    Akimoto S; Akakura K; Masai M; Shimazaki J
    Hinyokika Kiyo; 1991 Jan; 37(1):31-7. PubMed ID: 1707216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of total prostatectomy for prostatic cancer].
    Fujii A; Gohji K; Morisue K; Maruyama S; Kizaki T; Oka N
    Hinyokika Kiyo; 1994 Feb; 40(2):111-7. PubMed ID: 8128919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results].
    Peneau M; PiƩchaud T; Cariou G; Ragni E; Fontaine E; Fournier G
    Prog Urol; 1998 Dec; 8(6):977-93. PubMed ID: 9894256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant endocrine therapy after radical prostatectomy for stage D1 prostate carcinoma.
    Stein A; deKernion JB
    Semin Urol; 1990 Aug; 8(3):184-9. PubMed ID: 2119049
    [No Abstract]   [Full Text] [Related]  

  • 18. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
    Masai M; Akimoto S; Isaka S; Shimazaki J; Yatani R
    Hinyokika Kiyo; 1990 Jun; 36(6):667-71. PubMed ID: 1700585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of patients with clinical stage C prostate cancer treated by phototherapy and early orchiectomy. A retrospective analysis of 169 cases.
    Wiegel T; Tepel J; Schmidt R; Klosterhalfen H; Arps H; Berger P; Franke HD
    Strahlenther Onkol; 1996 Nov; 172(11):596-603. PubMed ID: 8946031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.